USPSTF maintains status quo on asymptomatic bacteriuria screening
September 24, 2019 -- The U.S. Preventive Services Task Force (USPSTF) essentially has reaffirmed its previous guidance on asymptomatic bacteriuria screening. In a recommendation statement published September 24 in the Journal of the American Medical Association, the USPSTF continued to recommend screening for asymptomatic bacteriuria in pregnant women with urine culture and continued not to recommend screening of nonpregnant adults.  Discuss
FDA seeks patient engagement in device design, development
September 24, 2019 -- The U.S. Food and Drug Administration (FDA) has published draft guidance on how device manufacturers should engage patients when designing medical devices.
CAP: Action on surprise medical bills may collapse, despite bipartisan support
September 23, 2019 -- ORLANDO, FL - Federal legislative efforts tackling surprise medical bills face an uncertain future, despite bipartisan support and the potential for billions of dollars in cost savings, presenters said during a session at the College of American Pathologists (CAP) annual meeting.  Discuss
ASCP recognizes best practices in test utilization
September 23, 2019 -- The American Society for Clinical Pathology (ASCP) announced this year's selection of Choosing Wisely Champions -- lab professionals who demonstrate mastery in ensuring the appropriateness of test ordering.
DeciBio acquires Emmes lab market information
September 23, 2019 -- Consulting and market intelligence firm DeciBio is acquiring databases in oncology and infectious disease testing from the Emmes Group in a deal set to take effect at the start of 2020.
ACLA blasts FDA's 'troubling actions' on pharmacogenetic tests
September 19, 2019 -- The American Clinical Laboratory Association (ACLA) has requested a meeting with officials at the U.S. Food and Drug Administration (FDA) regarding the legality of the agency's policies on laboratory-developed tests.  Discuss
Technology gives labs a hand with utilization management
September 16, 2019 -- Lab testing is notoriously prone to errors of overuse and underuse, with serious financial and clinical consequences. When word of mouth isn't enough to change course, machine-learning models and computerized systems for monitoring the use of tests can step in with objective support, new studies show.  Discuss
Roche's cobas pro clears FDA
September 16, 2019 -- Roche Diagnostics said the U.S. Food and Drug Administration (FDA) has cleared its cobas pro integrated solutions for high-volume clinical chemistry and immunochemistry testing in labs.
Sysmex drives Clinical Lab 2.0 anemia project
September 16, 2019 -- Sysmex America is providing a grant to the Clinical Lab 2.0 value-based laboratory initiative to support a multi-institutional demonstration project related to the early detection, intervention, and prevention of anemia.
Point-of-care testing tackles diabetes risk in Texas
September 12, 2019 -- One of the key advantages of point-of-care (POC) testing is the ability to offer test results within a matter of minutes, instead of several hours or a few days with central lab testing. Health officials in Texas were able to leverage POC technology to boost participation in a program designed to tackle one county's growing diabetes epidemic.  Discuss